Physician profile
Katrina Adele Romeo
NPI 1497414403
$850.24
in general payments reported to CMS, 2019-2025
11 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $227 · 2024: $514 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $850.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $850.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $247.48 | 2024-2025 | Zepbound |
| Novo Nordisk INC | $195.77 | 2023-2025 | Wegovy |
| Vivus LLC | $114.28 | 2024-2025 | Qsymia |
| Intra-Sana Laboratories | $92.26 | 2024 | Reltone 200 Mg, Reltone 400 Mg, Glycate |
| Mayne Pharma Commercial LLC | $77.60 | 2023 | |
| Currax Pharmaceuticals LLC | $31.76 | 2023-2024 | Contrave, Nexlizet, Nexletol |
| Daiichi Sankyo INC. | $22.93 | 2023 | Injectafer |
| Exeltis, USA INC. | $22.45 | 2023 | Slynd |
| Merck Sharp & Dohme LLC | $20.87 | 2023 | Gardasil 9 |
| Agile Therapeutics, INC. | $19.88 | 2023 | Twirla |
| Organon LLC | $4.96 | 2023 | Nexplanon |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Romeo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.